CN Patent

CN105503715A — 一种索拉非尼半甲苯磺酸盐多晶型及其制备方法

Assigned to Shenwei Pharmaceutical Group Co Ltd · Expires 2016-04-20 · 10y expired

What this patent protects

本发明涉及一种索拉非尼半甲苯磺酸盐一水合物、其结晶形式，其制备方法，含其药物组合物及其在抗癌药物中的应用。

USPTO Abstract

本发明涉及一种索拉非尼半甲苯磺酸盐一水合物、其结晶形式，其制备方法，含其药物组合物及其在抗癌药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN105503715A
Jurisdiction
CN
Classification
—
Expires
2016-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Shenwei Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.